Patients’ medical needs have no borders, and neither does our challenge to serve these patients. To provide treatment and extend our business as fast as we can, we work with a global network of members across various functions and regions.

*ASCA: Asia, South and Central America
*DX: Digital Transformation
*IP: Intellectual Property
*QA: Quality Assurance

Click here to enlarge the image

Management Functions and Units

Global Corporate Function

Heads of our eight Global Corporate Function, Global Corporate Strategy, Global Business Planning, Global Corporate Planning & Management, Global DX, Global HR, Global Legal & IP and Global Compliance & Risk Management, Global QA are member of the Corporate Leadership Team chair by COO and support our CEO and COO in developing comprehensive and consistent corporate strategies and ensuring smooth management of the Daiichi Sankyo Group.

Functional Units

Our three functional units, "Research & Development", "Technology" consisting of Pharmaceutical Technology, Supply Chain and process research functions of Biologics, and "Clinical Safety & Pharmacovigilance", help formulate and execute global strategies in their specialties. Each unit determines areas to be expanded globally, guides strategic planning and execution, and improves the efficiency of business operations.

Business Units

Our six business units are responsible for strategic planning and execution in the regions of our business operations.

Japan Business Unit

Oncology Business Unit

EU Specialty Business Unit

ASCA Business Unit

American Regent Business Unit

Daiichi Sankyo Healthcare Unit